Search research articles
Contact Us
Filters
Showing results (101-110 of 186) with videos related to
Page
of 19
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 12, 2022
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration
Elise Peter, Isabelle Treilleux, Valentin Wucher, et al.
International Journal of Cancer
|
February 8, 2013
Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells
Vanja Sisirak, Nelly Vey, Nadège Goutagny, et al.
Cancers
|
January 13, 2021
Molecular Characterization of Ovarian Yolk Sac Tumor (OYST)
Khalil Hodroj, Aleksandra Stevovic, Valery Attignon, et al.
Targeted Oncology
|
December 15, 2012
Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study
Olivier Trédan, Isabelle Treilleux, Qing Wang, et al.
The American Journal of Surgical Pathology
|
November 19, 2025
Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic Variants
Alexis Trecourt, Clémence Scard, Françoise Descotes, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 17, 2025
Breast Cancer Specificities of Patients With Anti-Ri Paraneoplastic Neurologic Syndromes
Elise Peter, Isabelle Treilleux, Valentin Wucher, et al.
BMC Cancer
|
June 1, 2011
Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer
Philippe A Cassier, Isabelle Treilleux, Thomas Bachelot, et al.
Breast Cancer Research : BCR
|
May 22, 2021
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant
Julien Jacquemetton, Loay Kassem, Coralie Poulard, et al.
Therapeutic Advances in Neurological Disorders
|
November 3, 2025
Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies
Antonio Farina, Elise Peter, Nolwenn Billet, et al.
Oncotarget
|
April 21, 2017
Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4
Amélie Royet, Laura Broutier, Marie-May Coissieux, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 186) with videos related to
Sort By:
Page
of 19
Neurology(R) Neuroimmunology & Neuroinflammation
|
July 12, 2022
Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration
Elise Peter, Isabelle Treilleux, Valentin Wucher, et al.
International Journal of Cancer
|
February 8, 2013
Breast cancer-derived transforming growth factor-β and tumor necrosis factor-α compromise interferon-α production by tumor-associated plasmacytoid dendritic cells
Vanja Sisirak, Nelly Vey, Nadège Goutagny, et al.
Cancers
|
January 13, 2021
Molecular Characterization of Ovarian Yolk Sac Tumor (OYST)
Khalil Hodroj, Aleksandra Stevovic, Valery Attignon, et al.
Targeted Oncology
|
December 15, 2012
Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study
Olivier Trédan, Isabelle Treilleux, Qing Wang, et al.
The American Journal of Surgical Pathology
|
November 19, 2025
Molecular Relationship Between Ovarian Sertoli-Leydig Cell Tumors and Their Heterologous Elements: Emphasis on the Possible Prognostic Significance of TERT Pathogenic Variants
Alexis Trecourt, Clémence Scard, Françoise Descotes, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
January 17, 2025
Breast Cancer Specificities of Patients With Anti-Ri Paraneoplastic Neurologic Syndromes
Elise Peter, Isabelle Treilleux, Valentin Wucher, et al.
BMC Cancer
|
June 1, 2011
Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer
Philippe A Cassier, Isabelle Treilleux, Thomas Bachelot, et al.
Breast Cancer Research : BCR
|
May 22, 2021
Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant
Julien Jacquemetton, Loay Kassem, Coralie Poulard, et al.
Therapeutic Advances in Neurological Disorders
|
November 3, 2025
Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies
Antonio Farina, Elise Peter, Nolwenn Billet, et al.
Oncotarget
|
April 21, 2017
Ephrin-B3 supports glioblastoma growth by inhibiting apoptosis induced by the dependence receptor EphA4
Amélie Royet, Laura Broutier, Marie-May Coissieux, et al.
Page
of 19